Clinical Trial Update: Renal and Bone Outcome After Switching Tenofovir to Different Antiretroviral Strategies

View source ↗

Summary

This clinical trial update reports renal and bone outcomes after switching from tenofovir disoproxil fumarate to alternative antiretroviral strategies in people…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• HIV Infection
• Osteoporosis

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas | Conditions: Renal Disease | Status: COMPLETED